Sarcopenia and Juvenile Idiopathic Arthritis
This study focuses on understanding muscle weakness and loss, known as sarcopenia, in teenagers and young adults living with Juvenile Idiopathic Arthritis (JIA). JIA is a long-lasting type of arthritis that starts in childhood. While we know sarcopenia can affect adults with similar conditions, it hasn't been well-studied in people with JIA. The researchers will screen patients aged 15 to 40 in France. They'll use simple tests like questionnaires, a handgrip strength test, and a special body scan called DEXA to measure muscles and body fat. They also want to understand how sarcopenia might affect daily life and overall well-being. The findings could help doctors better identify those at risk and provide earlier support, focusing on managing JIA, encouraging physical activity, and good nutrition.
At a glance
What is this study about?
This study wants to learn more about a condition called sarcopenia in people who have Juvenile Idiopathic Arthritis (JIA). JIA is a long-term type of arthritis that starts in childhood, causing joint pain and swelling. Sarcopenia means losing muscle strength and muscle mass. While we know this can happen in adults with inflammatory diseases, it’s not really been looked at closely in people with JIA.
The main goal of this study is to find out how common sarcopenia is among teenagers and young adults (aged 15 to 40) with JIA in France. The researchers also want to identify what might be linked to sarcopenia and how it affects people's daily lives and overall quality of life. They will gather information through questionnaires about diet, tiredness, and activity, measure handgrip strength, and use a special body scan called DEXA to check muscle and fat levels. They will also look at medical records.
By understanding more about sarcopenia in JIA, the study hopes to help doctors in the future. The findings could make it easier to spot patients who might be at risk of sarcopenia earlier. This could then lead to better and earlier support, focusing on managing their JIA, keeping active, and eating well. Ultimately, this could help people with JIA live better and healthier lives.
Key takeaways
- The study investigates muscle loss (sarcopenia) in young people and adults with JIA.
- It aims to understand how common sarcopenia is and what factors are linked to it.
- Participation involves questionnaires, a handgrip test, and a body scan (DEXA).
- Results could help doctors better identify and support JIA patients at risk in the future.
- It's a single visit assessment during routine care, with no new medicines for the study.
Who may be eligible?
To be part of this study, you need to be between 15 and 40 years old and have been diagnosed with Juvenile Idiopathic Arthritis (JIA). You must be receiving care at one of the participating hospitals in France and be covered by the French social security system (which handles healthcare costs). Most importantly, you and, if you are under 18, your parents or legal guardians, must agree to take part and sign a consent form.
There are some reasons why someone might not be able to join. For example, if you are under legal guardianship, not covered by social security, are pregnant, or if you wouldn't be able to do some of the simple tests required, like the handgrip strength test or the special body scan (DEXA). Also, if you find it difficult to understand questionnaires, you might not be suitable for this study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you between 15 and 40 years old?
- Have you been diagnosed with Juvenile Idiopathic Arthritis (JIA)?
- Are you a patient at a French hospital taking part in this study?
- Are you covered by French social security?
- Are you able to do a handgrip strength test and a DEXA scan?
What does participation involve?
If you decide to take part in this study, you'll have a special assessment during one of your regular rheumatology appointments. First, you'll get detailed information about the study, and if you agree, you'll sign a consent form (if you're under 18, your parents or guardians will too). During this single visit, you will have your handgrip strength measured using a special device. You'll also have a body scan called a DEXA to check your muscle and fat levels. Finally, you'll fill out some questionnaires about your diet, how tired you feel, how active you are, and how your JIA affects your daily life. The study will also collect some information from your medical records, like your JIA history and treatments. These assessments are all part of a single visit and there's no medication involved or long-term follow-up specifically for the study. If the study identifies sarcopenia, your doctor might suggest additional care as part of your usual treatment.
Potential risks and benefits
Locations (1)
- Marie MullerVerified postcodeReims, France
Common questions
What is Juvenile Idiopathic Arthritis (JIA)?
JIA is a type of arthritis that appears in childhood, causing joint pain, swelling, and stiffness that can last a long time.
What is sarcopenia?
Sarcopenia means having less muscle strength and muscle mass. It can make everyday activities harder.
What is a DEXA scan?
A DEXA scan is a quick, low-dose X-ray that measures bone density, but in this study, it's used to measure muscle and fat in your body.
Will I have to take any new medicines?
No, this study does not involve taking any new medicines. It focuses on assessments and gathering information.
How long will my participation last?
Your participation will involve a single set of assessments during one of your regular hospital visits.
How to find out more
Ambre HITTINGER-ROUX
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.